Umbilical Hernia

0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

QT
Q TherapeuticsUT - Salt Lake City
1 program
DefluxN/A1 trial
Active Trials
NCT00706329TerminatedEst. Mar 2009
City Therapeutics
City TherapeuticsMA - Cambridge
1 program
General AnesthesiaN/A1 trial
Active Trials
NCT06426225CompletedEst. Aug 2024

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
City TherapeuticsGeneral Anesthesia
Q TherapeuticsDeflux

Clinical Trials (2)

NCT06426225City TherapeuticsGeneral Anesthesia

Spinal Or General Anesthesia For Umblical Hernia Surgery

Start: May 2024Est. completion: Aug 2024
N/ACompleted
NCT00706329Q TherapeuticsDeflux

Minimally Invasive Closure of Umbilical Hernias

Start: Apr 2008Est. completion: Mar 2009
N/ATerminated

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 companies competing in this space